login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Terumo introduces Azur Detachable 35 Peripheral Framing Coil


Monday, 02 Apr 2012 12:34
Azur coils
Azur coils

Terumo Interventional Systems, one of the leading manufacturers of guidewires, catheters, sheaths, and embolization products, has announced the US availability of the Azur D35 Framing Coil for peripheral embolization procedures.


Azur is indicated for peripheral embolization procedures where a scaffolding structure is needed, such as: hypogastric artery embolization; peripheral arteriovenous malformations and fistulas; endoleaks; visceral aneurysms; and venous applications. The detachable embolic platform forms a spherical 3-dimensional shape when deployed and is designed to control the first coil deployment, when a standard coil would not suffice due to high flow and high pressures.


“The new Azur D35 Framing Coils’ innovative technology offers interventional radiologists and vascular surgeons options in challenging, high-flow procedures,” said Chris Pearson, vice president, Marketing, Terumo Interventional Systems. “These detachable framing coils afford greater filling capacity, packing density, and mechanical occlusion, particularly in the treatment of high-flow and challenging blood vessels, vascular malformations, and aneurysms.”


“The detachable technology allows the physician to optimise the framing coil placement, creating support for subsequent coils,” said Pearson. “Azur D35 Hydrogel coils expand gradually upon exposure to blood, which provides improved volumetric filling allowing highly effective, targeted embolization.”




Add New Comment

Most popular


DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients
Friday, 29 Aug 2014
The multicentre, 800-patient study also demonstrated that directional atherectomy was non-inferior for treating peripheral arterial disease in patients with diabetes compared with those without ... DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients

First varicose vein patient treated with FDA-approved Varithena (polidocanol injectable foam) 1%
Tuesday, 12 Aug 2014
The first varicose vein patient has been treated with Varithena, the only FDA-approved foam for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities ... First varicose vein patient treated with FDA-approved Varithena (polidocanol injectable foam) 1%

Arterial embolization works to alleviate knee pain in mild to moderate osteoarthritis
Monday, 21 Jul 2014
A small study conducted in Japan, published in CardioVascular and Interventional Radiology in July 2014, demonstrates that transcatheter arterial embolization is feasible and that it rapidly relieves ... Arterial embolization works to alleviate knee pain in mild to moderate osteoarthritis

Features


The promise of chemical renal denervation
Friday, 05 Sep 2014
Tim A Fischell writes that chemical renal denervation using ethanol may have numerous advantages over energy-based “burning” technologies. The promise of chemical renal denervation

Is all heat the same and does catheter design matter?
Wednesday, 13 Aug 2014
Mark S Whiteley writes that it is essential that every doctor practising varicose vein surgery has a good understanding of the principles of endovenous thermoablation. Is all heat the same and does catheter design matter?

Profiles


Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

James B Spies
Friday, 16 May 2014
The evolution of embolization over the past decade has been remarkable and it has fundamentally ... James B Spies

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions